Acorn Capital Advisors, LLC Top Holdings and 13F Report (2026) About Acorn Capital Advisors, LLCInvestment ActivityAcorn Capital Advisors, LLC has $351.84 million in total holdings as of March 31, 2026.Acorn Capital Advisors, LLC owns shares of 22 different stocks, but just 8 companies or ETFs make up 80% of its holdings.Approximately 6.44% of the portfolio was purchased this quarter.About 0.90% of the portfolio was sold this quarter.This quarter, Acorn Capital Advisors, LLC has purchased 21 new stocks and bought additional shares in 4 stocks.Acorn Capital Advisors, LLC sold shares of 6 stocks and completely divested from 1 stock this quarter.Largest Holdings Terns Pharmaceuticals $92,063,038CG ONCOLOGY INC $76,579,958Urogen Pharma $30,088,092Puma Biotechnology $26,399,001Trevi Therapeutics $25,587,989 Largest New Holdings this Quarter 008064206 - JADE BIOSCEINCES INC $11,053,978 Holding48576U205 - KARYOPHARM THERAPEUTICS INC $1,603,191 Holding Largest Purchases this Quarter JADE BIOSCEINCES INC 786,760 shares (about $11.05M)Candel Therapeutics 917,431 shares (about $4.51M)Urogen Pharma 225,000 shares (about $4.05M)KARYOPHARM THERAPEUTICS INC 287,826 shares (about $1.60M)LEONABIO, INC. 132,800 shares (about $1.37M) Largest Sales this Quarter Q32 BIO INC. 178,373 shares (about $1.15M)JASPER THERAPEUTICS 375,000 shares (about $330.00K)Cardiff Oncology 200,000 shares (about $324.00K)X4 Pharmaceuticals 39,310 shares (about $162.35K)HELUS PHARMA INC. 32,757 shares (about $157.23K) Sector Allocation Over TimeMap of 500 Largest Holdings ofAcorn Capital Advisors, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorTERNTerns Pharmaceuticals$92,063,0380.0%1,746,26426.2%MedicalCG ONCOLOGY INC$76,579,958$67,740 â–¼-0.1%1,130,50121.8%COMURGNUrogen Pharma$30,088,092$4,045,500 â–²15.5%1,673,4208.6%MedicalPBYIPuma Biotechnology$26,399,0010.0%4,131,2997.5%MedicalTRVITrevi Therapeutics$25,587,9890.0%2,144,8447.3%MedicalCADLCandel Therapeutics$17,209,904$4,513,760 â–²35.6%3,497,9484.9%MedicalBICARA THERAPEUTICS$12,796,8600.0%643,3823.6%COMONKURE THERAPEUTICS INC$11,756,2500.0%2,839,6743.3%CLASS A COMJADE BIOSCEINCES INC$11,053,978$11,053,978 â–²New Holding786,7603.1%COM NEWTARAProtara Therapeutics$9,128,5190.0%1,752,1152.6%MedicalVSTMVerastem$7,786,5110.0%1,469,1532.2%MedicalHELUS PHARMA INC.$7,393,277$157,234 â–¼-2.1%1,540,2662.1%COM STKLEONABIO, INC.$6,523,061$1,365,184 â–²26.5%634,5391.9%COMMON STOCKAURAAura Biosciences$3,985,5270.0%595,7441.1%MedicalAADIAadi Bioscience$3,930,8020.0%1,139,3631.1%MedicalCRDFCardiff Oncology$2,854,576$324,000 â–¼-10.2%1,762,0840.8%MedicalQ32 BIO INC.$2,022,634$1,145,155 â–¼-36.1%315,0520.6%COMKARYOPHARM THERAPEUTICS INC$1,603,191$1,603,191 â–²New Holding287,8260.5%COMMON STOCKJASPER THERAPEUTICS$1,242,113$330,000 â–¼-21.0%1,411,4920.4%COMXFORX4 Pharmaceuticals$966,583$162,351 â–¼-14.4%234,0390.3%MedicalBCABBioAtla$865,015$91,397 â–²11.8%5,406,3450.2%MedicalVYNEVYNE Therapeutics$8550.0%1,4250.0%MedicalACRVAcrivon Therapeutics$0$976,622 â–¼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
